¤°»ò¬O¶Ê¯v ¤@¯ë¤H¹ï¶Ê¯vªº»~¸Ñ
¶Ê¯vªº¬ì¾Ç¬ã¨s¤ÎÂå¾Ç¬ÉªºªÖ©w

¤°»ò¬O¶Ê¯v

¨Æ¹êµý©ú¶Ê¯v¬O¤@ºØ¨ã¦³¦hºØªvÀø¥Î³~ .... ªº¯u¹ê²{¶H

--- <Scientific America>

­n©ú¥Õ¶Ê¯vªº­ì²z¡A¥²¥ý­n©ú¥Õ¤HÃþ¤ßÆFªº¹B§@¡C¤HÃþ¤ßÆFªº¹B§@°ò¥»¤W¥i¥H¤À¬°¨â­Ó³¡¥÷ - ·NÃÑ»P¼ç·NÃÑ¡C·NÃÑ«üªº¬O±±¨î§Ú­Ì²z©Ê¦æ¬°ªº¤ß´¼¡A¥]¬AÅÞ¿è¤ÀªR¡A¥¼¨Ó­p¹º¡A­pºâµ¥µ¥¡C·NÃѪº¹B§@¦û¤HÃþ¤ßÆF¹B§@¤Ö©ó10%¡C ¼ç·NÃѪº·§©À³Ì¦­¥Ñ¤W¤@¥@¬ö¤ß²z¾Ç©l¯ª©»¬¥¨Ì¼w (Freud) ©Ò´£¥X¡C¼ç·NÃѦû¤HÃþ¤ßÆF¹B§@¶W¹L90%¡C ¥H¤U¥u¦CÁ|¼ç·NÃÑ¥\¯àªº¤@¤Ö³¡¥÷¡A¥]¬A:

±±¨î°ò¥»¥Í²z¥\¯à¨Ò¦p¤ß¸õ¡A©I§l°Ê§@¡A¥¿ /°Æ¥æ·P¯«¸g¨t²Î¡A±Æ¬ª¨t²Î¡AºÎ¯v¾÷¨î¡A¨­Ê^¦Û°Ê­×¸É¥\¯àµ¥¡C
¶J¦s¤@¤Á¨Æ±¡ªº°O¾Ð¡C
±±¨î§Ú­Ì¹ï¨Æ±¡ªº±¡ºü¤ÏÀ³¡C
¤@¤Á²ßºD©Ê¦æ¬°ªº±±¨î¤¤¤ß¡C
­t³d¹Ú¹Òªº³Ð³y¡C
ª½Ä±ªº¨Ó·½¡C

¥H¤Uªº¦B¤s¯à°÷»¡©ú·NÃÑ»P¼ç·NÃѪºÃö«Y :

 

®ü­±¤W¨£¨ìªº¦B¤s¤@¨¤¬O§Ú­Ìªº·NÃÑ¡C®ü­±¤U¦û³Ì¤j³¡¥÷¦Óªí­±¤W¤£¯à¬Ý¨£ªº¬O¼ç·NÃÑ¡C

·NÃÑ»P¼ç·NÃѤ§¶¡ªº¹B§@¬O«D±`¥©§®ªº¡C¨Ò¦p¤@­Ó¤pªB¤Í¾Ç²ß¦p¦óÀ¿¤ú¡A¦b³Ìªìªº®É¶¡¡A¥L­n¨è·N¦a¸ò±q¥¿½TªºÀ¿¤úªº°Ê§@¡C¦ý¤@¥¹·í¥L¯Â¼ô¦a´x´¤À¿¤úªº°Ê§@«á¡AÀ¿¤ú°Ê§@ªº¦Û°Ê°õ¦æµ{¦¡´N·|¦b¼ç·NÃѤ¤«Ø¥ß°_¨Ó¡C¤U¤@¦¸¥L«K¤£¦A»Ý­n«ä¦Ò¡A¦Û°Ê¦a«K¯à°÷¨Ì·Ó¥¿½Tªº°Ê§@¡C³o¼Ë¡A·NÃÑ«K¯à°÷Ä˪ŧó¦h®É¶¡¥h¾Ç²ß¨ä¥L·sªº¨Æª«¡C·Q¹³¦³¤@­Ó¤H¦pªG¥L¨C¤Ñ°_§É«á³£­n¥h­«·s¾Ç²ßÀ¿¤ú¡A·|¦³«ç¼Ëªº«áªG ?

®Ú¾Ú¬ì¾Ç®a¬ã¨s¤j³¡¥÷¤H¦³¶W¹L 99% ¼ç¯à¦³«Ýµo®i¥X¨Ó¡A«üªº´N¬O¶}±Ò¼ç·NÃѪº¯à¤O¡AÅý§Ú¦A¥Î¥t¤@­Ó¨Ò¤l¸ÑÄÀ¡CÁ|´îªÎ¬°¨Ò¡A·í¤@­Ó¦¶¥j¤O¨g¼öªÌ²z©Ê¤W¨M©w¤£¦A¶i­¹¦¶¥j¤O¡A¦ý¥LµoıÁ`¬O±±¨î¤£¤F¦Û¤vªº¦æ¬°¡AÁ`¬O§Ô¤£¦í­n­¹¡C¨ìÀY¨Ó¤S³d³Æ¦Û¤v¡C¨Æ¹ê¤W¡A¥L¨Ã¤£»Ý­n³d³Æ¦Û¤v¡A¦]¬°¥L¨S¦³ª`·N¨ì¡A¦b¨M©w©ñ±ó¦¶¥j¤Oªº¹Lµ{¤¤¡A¥L¥u¬O¹B¥Î10%·NÃѪº¤O¶q©ÎªÌ§ó¤p¡C¥L¨Ã¨S¦³§ïÅܼç·NÃѤ¤¦³Ãö­¹¦¶¥j¤O¦æ¬°ªºµ{¦¡¡C©Ò¥H·í¥L¬Ý¨£¦¶¥j¤Oªº®É­Ô¡A¨¥­Ó¶i­¹¦¶¥j¤Oªº¦æ¬°µ{¦¡¤S·|¦A¦¸³Q±Ò°Ê°_¨Ó¡C

¦ý¬O¶Ê¯v¥i¥H§ï¼g³o¨Çµ{¦¡¡C·í¤@­Ó¤H¶i¤J¶Ê¯vª¬ºA¤§«á¡A­t³d²z©Ê¤ÀªR¡A§å§Pªº·NÃѤ§ªù´N·|¥´¶}¡C¶Ê¯v®v¥i¥H¥©§®¦a¶i¤J¼ç·NÃѦw¸Ë·sªº¦æ¬°µ{¦¡¡C¨Ò¦p´î¤Ö¶i­¹¦¶¥j¤O¡A¨ú¦Ó¥N¤§ªº¬O·sÂAªº¤ôªG¡A½­µæ¡C¤@¥¹·sªº¦æ¬°µ{¦¡³Q¦w¸Ë¡A¥H¤Î±j¤Æ¤§«á¡A·í®É¤Hªº¦æ¬°´N·|§¹¥þ§ïÅܹL¨Ó¡C

¥H¤Wªº¨Ò¤l¥i¥Hºâ¬O¶Ê¯v³Ì²³æªº´n©À¡C·íµM¶Ê¯vªºÀ³¥Î½d³òµ´¤£¥u©ó¦¹¡A¶Ê¯v¥i¥HªvÀø¤ß²z¤WºØºØ¯gª¬¥]¬A¼~Æ{¯g¡A¥¢¯v¡A¯Ê¥F¦Û«H¤ß¡A§ïµ½¤H»ÚÃö«Yµ¥µ¥¡C

(¸Ô±¡½Ð°Ñ¦Ò"±¡ºüµÎ¾É»P¦æ¬°­×¥¿" ªvÀø°·±d°ÝÃD­Ó®×¹ê¿ý)

  ¦^³»³¡

¤@¯ë¤H¹ï¶Ê¯vªº»~¸Ñ

¹L©¹ªº¤@¨Ç¤£¹ê³ø¾É¡A¥O¤@¯ë¤H¹ï¶Ê¯vªvÀø·|¦³¤£¦Pµ{«×ªº»~¸Ñ¡C¥]¬A :

»~¸Ñ¤@ : ·í¨Æ¤H·|¥¢¥h±±¨î¡C

¨Æ¹ê¤W¡A¶Ê¯v¥u¤£¹L¬O¤@­Ó©ñÃPªºª¬ºA¡A¦³ÂIÃþ¦ü®û¦b¼ö¤ô¯D¤¤ªº·Pı¡A¤S©ÎªÌ½ö¦b¨FÅy¤U¨É¨üµÛ®üÃä§j¨Óªº·L­·¤@¼Ë¡C©Ò¥H¡A¦b¾ã­Ó¶Ê¯vªvÀøªº¹Lµ{¤¤¡A·í¨Æ¤H¯à°÷¦b¥ô¦ó®É­Ô²×¤î¹Lµ{¡A¨Ãªð¦^·NÃѪ¬ºA¡C

»~¸Ñ¤G : ¶Ê¯v¥O·í¨Æ¤H°µ¥X¤@¨Ç¹H¤Ï¥L·NÄ@ªº¨Æ¡C

µL¼Æ¬ã¨sµý©ú¡A°²³]·í¨Æ¤H¤£Ä@·N§ïÅܪº¸Ü¡AµL½×¶Ê¯vªvÀø®v¥ÎºÉ¤°»ò¤èªk¡A¤]¤£¯à¹H¤Ï¥Lªº·NÄ@¦Ó§ïÅÜ¥L¡C©Ò¥H¡A±±¨îÅvÁ`¬O¦b·í¨Æ¤Hªº¤â¤¤¡C

»~¸Ñ¤T : ·í¨Æ¤H¥i¯à¤£¦Aµd¿ô

¦pªG·í¨Æ¤H¥»¨­¤v¸g«Ü¯h­Â¡A¥L¥i¯à·|¦b¶Ê¯v¹Lµ{¤¤¶i¤JºÎ¯vª¬ºA¡C³o¬O¨S¦³°ÝÃDªº¡A¹L¤@·|·í¥L¥ð®§¨¬°÷¤§«á¡A¥L·|¦ÛµM¦aºÎ¿ô¡AµM«á·P¨ì¤ñ¶Ê¯v«eºë¯«·Øµo¡C¤@¯ë¨Ó»¡¦³¨¬°÷¸gÅ窺¶Ê¯vªvÀø®v¡A·íÆ[¹î¨ì·í¨Æ¤H«Ü¯h­Âªº®É­Ô¡A·|«ØÄ³·í¨Æ¤H¬ù¨£¤U¤@¦¸¡C¦]¬°¡A³q±`¨ÓÁ¿¡A³Ì¦³®Äªº¶Ê¯vª¬ºA¤£¬O²`«×¶Ê¯vª¬ºA©ÎºÎ¯vª¬ºA¡A¦Ó¬O¤¤«×©Î»´«×ªº¶Ê¯vª¬ºA¡C

»~¸Ñ¥| : ¥u¦³·N§ÓÁ¡®zªº¤H¤~·|³Q¶Ê¯v

¥ô¦ó¤H³£¥i¥H¶i¤J¶Ê¯vª¬ºA¡C¦]¬°¶Ê¯vª¬ºA¥»¨­´N¬O¤@ºØ»P¥Í­Ñ¨Óªº¡A¦ÛµMªºª¬ºA¡C§Ú­Ì¨C¤é³£·|¶i¤J¡A¶i¥X«Ü¦h¶Ê¯vª¬ºA¡A¨Ò¦p : «D±`±Mª`¦a¾\Ū¤@¥»®Ñ¡A®û¦b¼ö¤ô¯D¤¤¡A¦b¹q¼v»È¹õ«e¬ÝµÛÅK¹F¥§¸¹¤U¨I¡A©ÎªÌ»P·R«Q¦b¶À©ü¤i¶§±×·Ó¤Uº©¨B¨FÅyµ¥¡A³£¬O¤@¨Ç»´«×ªº¶Ê¯vª¬ºA¡C¨C·í§A«Ü©ñÃP¦Ó¦P®É±Mª`ªº®É­Ô¡A§A«K³B©ó¶Ê¯vª¬ºA¡C¦b³o­Óª¬ºA¤§¤¤¸£¹qªi§Î¦¨ªüº¸ªkªi¡C³o´N¬O¤HÃþ¾Ç²ß¯à¤O¡A³Ð·N³Ì±jªº®É­Ô¡A¦nªº¶Ê¯vªvÀø®v·|¹B¥Î¥©§®ªº»y¨¥§Þ¥©§â·í®É¤H±a¨ì³o­Óª¬ºA¡AµM«á°µªvÀøªº¤u§@¡C¦³¨Ç¸û¬°²z©ÊÅ޿誺¤Hªº½TÃø¶i¤J¶Ê¯vª¬ºA¡C¦ý³o¨Ã¤£ªí¥Ü¥L­Ì¤£¯à¶Ê¯v¡A³oªí¥Ü¶Ê¯vªvÀø®v»Ý­n¨Ì¾a±Ó¾UªºÆ[¹î¤O¡A»P·í¨Æ¤H«Ø¥ß§ó²`ªº«H¥ôÃö«Y¡A¥H¤Î°ª¼h¦¸ªº»y¨¥¼Ò¦¡µ¥¡AÀ°§U¹ï¤è¶i¤J¶Ê¯vª¬ºA¡CÀu¨qªº¶Ê¯vªvÀø®v§¡¾Ö¦³³o¨Ç¯à¤O¡C

»~¸Ñ¤­ : ¶Ê¯v¬O¦MÀIªº

¥t¥~¡A¶Ê¯vªvÀø¤j®v¥ç¬OAmerican Council of Hypnotist Examinerªº¥D®uGil Boyneªºµû»y "¦b±µªñ40¦~¥H¤Î¶W¹L40,000¤p®Éªº¶Ê ¯v ªvÀø¸gÅ礧¤¤¡A§Ú±q¨S¦³¨£¹L©ÎÅ¥¹L¶Ê²´±a¨Ó¬Æ»ò®`³B¡C"

»~¸Ñ¤» : ¶Ê¯v¥u¤£¹L¬O¦Û´Û´Û¤H

·í¤@­Ó¤H³Q¤½¥qµô¨«¡A¥L¦w¼¢¦Û¤v»¡¡A¥b¦~¤º¤@©w·|¤¤¤»¦X±m¡A©Ò¥H¤£¥Î¾á¤ß¡A³o¼Ëªº¤ßºA¬Û«H§A¤]·|¦P·N¬O¦Û´Û´Û¤H¡C¦]¬°³o¼Ëªº«H©À¬OÁ¡®zªº¡A¦b²{¹ê¥@¬É¤¤½T¹êÃø¥H¹üÅV¥X¨Ó¡C¦ý¶Ê¯v¨Ã¤£¬O³o¼Ë¡A´I¦³¸gÅ窺¶Ê¯vªvÀø®v·|¦]À³·í¨Æ¤Hªº¹ê»Ú»Ý­n¡A¬°¥L³]­p¥X¾A¦X·í¨Æ¤Hªº¶Ê¯v«ü¥O¡A¦Ó³o¨Ç«ü¥O¬O·|³z¹L·í¨Æ¤H·sªº¦æ¬°¦Ó¹üÅã¥X¨Ó¡C

  ¦^³»³¡

¶Ê¯vªº¬ì¾Ç¬ã¨s¤ÎÂå¾Ç¬ÉªºªÖ©w

¡u¬ì¾Çªº­«ÂI¨Ã«D½ÆÂøªº¼Æ¾Ç¤½¦¡©ÎªÌ¬YºØ§Î¦¡ªº¹êÅç¡C¬ì¾Çªº®Ö¤ß¬O¤@ºØ±Ó¾Uªº¸Û¹êºA«×, ¥Øªº´N¬O­nª¾¹D¦³¤°»ò¨Æ±¡¥¿¦bµo¥Í¡C¡v

--------- ª«²z¾Ç®a ¨F®Ô£»«Où ¥v¯Ç

«Ü¦h¤H¹ï¶Ê¯v·P¨ì¯«¯¦¡A¬Æ­P¤j³¡¤À¤H¹ï¶Ê¯vªº²z¸Ñ³£¥u¬O¶Ê¯v®v¤â¤W´¤µÛ¤@­ÓÄÁÂ\¡AµM«á§i¶D¹ï¤è«Ü§Ö«K·|¶i¤J¶Ê¯vª¬ºA¡C¨Æ¹ê¤W¡A·í¤µªºµ´¤j¦h¼Æ¶Ê¯vªvÀø®v¤w¸g¤£¦A¨Ï¥Î³oºØ¹L®Éªº§Þ³N¤F¡C«Ü¦h¤£¤F¸Ñ¶Ê¯vªº¤H³£·|°Ý , ¶Ê¯v¬O§_¯uªº¯à°÷±a¨Ó¹ê½èªº§ïÅÜ , §í©Î¥u¬O¦Û´Û´Û¤H ? §A­Ì³£«H¿à¬ì¾Ç¡A»{¬°¬ì¾Ç¨ã¦³«ÈÆ[©Ê¡C ¬JµM¦p¦¹ , §Ú­Ì´N°Ñ¦Ò¤@¨Ç¦³Ãö¶Ê¯vªºªñ¥N¬ì¾Ç¬ã¨s§a¡C¨Æ¹ê¤W¡A±q¤W¤@­Ó¥@¬ö¤¤¨ì¥»¥@¬ö³o¤@¬q®É¶¡¤§¤º¡A¤j¶q¤ß²z¾Ç®a¡BÂå¥Í¡B¯«¸g¬ì¾Ç®a´¿¸g°µ¹L¤j¤j¤p¤p¦UºØ¤£¦Pªº¶Ê¯v¹êÅç¡C¥H¤U¦CÁ|¤F¨ä¤¤¤@¤p³¡¤À¥H§@°Ñ¦Ò :

¬ü°ê¤@¥÷¾Ç³N´Á¥Z ¡§Journal of Consulting and Clinical Psychology¡¨´¿³ø¾É¬ü°ê«X¥è«X¦{¥ß¤j¾Ç¥Ñ¤T¦ì±M®a²Õ¦¨ªº¬ã¨s¤p²Õ¦³Ãö¶Ê¯v¯à°÷´£¤É¨­Åé§K¬Ì¯à¤Oªº¬ã¨s³ø§i¡C³o¤T¦ì±M®a¥]¬A¤ß²z¤Îºë¯«¯f¾Ç±Ð±Â Janice Kiecolt Glaserl, ¤ú©P¯f¾Ç±Ð±Â Phillip Marucha, ¥H¤Î¤À¤l¯f¬r¾Ç±Ð±Â Ronald Glaser¡C¥L­Ì´¿¥H33¦ìÂå¬ì¤Î¤ú¬ì¾Ç¥Í§@¬°¬ã¨s¹ï¹³¡C 33¦ì¾Ç¥Í³Q¤À¬°¨â²Õ¡CA²Õ¾Ç¥Í³Q±Ð±Â¦Û§Ú¶Ê¯v§Þ¥©, ¨Ã¦b·Ç³Æ¾Ç´Á¦Ò¸Õªº°ªÀ£®É¶¡¸g±`½m²ß¦Û§Ú¶Ê¯v¡CB²Õ¾Ç¥Í¬O¹ï·Ó²Õ, ¨Ã¨S¦³±Ð±Â¦Û§Ú¶Ê¯v¡C¦b¨â²Õ¾Ç¥Í¦Ò¸Õ¶}©l«e¤T¤é¨C²Õ©â¨ú¦å²G¼Ë¥»¤ÆÅç¡Cµ²ªG, A²Õ¾Ç¥ÍªºT ¥Õ¦å²Ó­M¬¡ÅD²v(¥Î¥H¶q«×§K¬Ì¤Oªº«ü¼Ð)¥­§¡¤W¤É¤F8%, ¦ÓB²Õ«h¥­§¡¤U­°¤F33%¡C¥t¥~, ¬ã¨s¥çµo²{·U¸g±`½m²ß¶Ê¯v§Þ¥©ªº¾Ç¥Í, ¥L­Ìªº§K¬Ì¤ÏÀ³·U¦n¡C (Janice Kiecolt Glaserl)

³o­Ó¬ã¨sÅã¥Ü , ·í¤Hªø´Á¨­³BÀ£¤OªºÀô¹Ò, §K¬Ì¤O·|¤U­°¡C¶Ê¯v¤£¦ý¯à°÷´î»´À£¤O, ¦Ó¥B¯à°÷¦³®Ä´£¤É¨­Åé§K¬Ì¾÷¯à¡C¦]¦¹, ¹ï©ó¥Í¬¡ºò±iªº³£¥«¤H¨Ó»¡, ¶Ê¯v¬O¥­¿Å¨­¤ß¨t²Îªº¦³®Ä¤u¨ã¡C

¦b¥t¤@­Ó¦³Ãö¶Ê¯vªº¬ã¨s¤¤ (Olness, MacDonald, and Uden 1987) ¡A 28 ¦ì¦~ÄÖ¤¶¥G 6-12 ·³±w¦³°¾ÀYµhªº¨àµ£³Q¦w±Æ§@¬°¹êÅç¹ï¶H¡C¥L­Ì³QÀH¾÷¦w±Æ¬Y¨Ç¤£¦PªºªvÀø±¡ªp¤¤¡C¨ä¤¤¤@ºØ»Ý­nªA¥Î¯à°÷ªvÀø¯U¤ß¯g¡B­ìµo©Ê°ª¦åÀ£¥H¤Î°¾ÀYµhµ¥ªº‰xª«¤ß±o¦w (Propranolol) ¡C¥t¤@ºØ¥u¬O±µ¨ü¦w¼¢¾¯®ÄÀ³ (Placebo Effect) ªvÀøµ¥¡C¥L­Ì»Ý­n±µ¨ü¤j¬ù¤C­Ó¤ëªºªvÀø¡C¤C­Ó¤ë¤§«á¡A©Ò¦³¨àµ£³Q±Ð±Â¦Û§Ú¶Ê¯v§Þ¥©¡A³sÁZ¶i¦æ¤T­Ó¤ë¡C³o¨Ç§Þ¥©¥]¬A¶Ê¯v©ñÃP¡B·Q¹³¶}¤ß´r§Öªº´º¹³¥H¤Îµh·¡±±¨îµ¥¡C³o­Ó¬ã¨sªºµ²ªGÅã¥Ü¡A¸g¹L¦Û§Ú¶Ê¯vªº°V½m»P¤Î½m²ß¤§«á¡A°¾ÀYµh¥X²{ªºÀW²v¤j´T¤U­°¡A¥i¬O¦b±µ¨ü¦Û§Ú¶Ê¯v¤§«e¡A¥L­Ìªº¯fúG¨Ã¨S¦³¤Q¤À©úÅ㪺§ï¶i¡C

¬ü°ê±KªÛ®Ú¤j¾Ç (University of Michigan) ¤p¨à¬ì¾Ç¨t´¿¸g¤½¶}¤@­Ó¦³Ãö¤p¨à©]§¿ªº¬ã¨s¡C 50 ¦ì¦~ÄÖ¤¶¥G 5 ¡V 16 ·³¸g±`¦b§É¤W©]§¿ªº¨àµ£ (30 ­Ó¨k«Ä 20 ­Ó¤k«Ä ) ³Q¿ï¾Ü¬°¹êÅç¹ï¶H¡C¨ä¤¤¤@²Õ±µ¨üÃĪ«ªvÀø , »Ý­nªA¥Î¤@ºØ¥s°µ imipramine ªºßÓª«¡C Imipramine ¬O¤@ºØ¼W¥[§¿¹Dªý¤O¤Î»H¯Ö®e¿nªºßÓª«¡C¥t¥~¤@²Õ³Q±µ¨ü¶Ê¯v¡C¶Ê¯vªº¤º®e¥]¬A·t¥Ü³o¨Ç¨àµ£ªº¼ç·NÃÑ·í»H¯Ö¤w¸g¥Rº¡¤F§¿²G¡A¥L­Ì«K·|¦Û°ÊºÎ¿ô¡A¨Ã¥B¥h¬~¤â¶¡±Æ§¿µM«á¦A¦¸¦^¨ì§É¤WºÎµÛµ¥¡C ³o­Ó¬ã¨sºû«ù¤F¤E­Ó¤ë , ¥H¤U´N¬O¦³Ãö³o­Ó¬ã¨sªºµ²ªG :

¶Ê¯v¤F²Õ§O

Imipamine ²Õ§O

¥¿­±¤ÏÀ³

¨S¦³¥ô¦ó¤ÏÀ³

¥¿­±¤ÏÀ³

¨S¦³¥ô¦ó¤ÏÀ³

17/25 (68%)

8/25 (32%)

6/25(24%)

19/25(76%)

¡u ¨S¦³¥ô¦ó¤ÏÀ³ ¡v «üªº´N¬O§¿§Éªº±¡úG¨S¦³§ïÅÜ¡C
¡u¥¿­± ¤ÏÀ³ ¡v «üªº´N¬O§¿§Éªº±¡úG§¹¥þ®ø¥¢©ÎªÌ¦¸¼Æ´î§C¡C

±q¥H¤W³o­Ó¬ã¨sµ²ªG¥i¥HÅã¥Ü¡A¶Ê¯v¤ñ°_¶Ç²Î Imipamine ÃĪ«ªº®ÄªG§ó¥[²z·Q¡A¦Ó¥B¨S¦³¥ô¦ó°Æ§@¥Î¡C

¶Ê¯v¹ï©óªvÀø¥Ö½§¯e¯f¥ç¯à°÷Åã¥Ü¬Û·íº¡·Nªº®ÄªG ¡C¦b¥t¤@­ÓªvÀø¬Ð (Wart) ªº¬ã¨s¤¤ , ¥|¤Q¦ì¯f¤H³Q¤À°t¬°¥|­Ó²Õ§O¡C²Ä¤@²Õ§O³Q¦w±Æ±µ¨ü¶Ê¯vªvÀø¡A²Ä¤G­Ó²Õ§O±µ¨ü¶Ç²ÎªºÃĪ«ªvÀø¡A²Ä¤T­Ó²Õ§O¬O¦w¼¢¾¯®ÄÀ³²Õ§O , ²Ä¥|­Ó²Õ§O¨S¦³±µ¨ü¥ô¦óªvÀø¡Cµ²ªGÅã¥Ü¡A¥u¦³²Ä¤@²Õªº¯f¤H¬Ðªº¼Æ¥Ø©úÅã¦a´î¤Ö¡C (Spano, Williams, & Gwynn, 1990)

¹ï©ó«°¥«¤Hªº¤ß²z±þ¤â§íÆ{¯g (Depression) ¡A¶Ê¯v§ó¥[¬O«Ü¦³®ÄªºªvÀø¨}¤è ¡C´¿¸g¦³¤@­Ó¬ã¨s±w¦³ªø´ÁÃö¸`ª¢µh¯gªº¯f¤H¡A¥L­Ì³£±a¦³µJ¼{¤Î§íÆ{¯gª¬¡C§íÆ{¯g¯f±wªÌ¨­Å餺ªº¤º°ØÊy (Endorphins) §t¶q³£¤ñ¥¿±`¤H§C¡C³o¨Ç¯f¤H¦b±µ¨ü¶Ê¯vªvÀø¤@¬q®É¶¡¤§«á¡A¥L­Ìªº¨­Åéµh·¡¡AµJ¼{¡A¥H¤Î§íÆ{¯gª¬³£¦³Åã¦a´î»´¡C¤£¦ý¦p¦¹¡A¬ã¨sµ²ªGÅã¥Ü¥L­Ì¨­Å餤ªº¤º°ØÊy§t¶q¥ç©úÅã¦a¼W¥[¡C (Domangue 1985)

¹ï©ó¤@¨Ç¯f±¡®e©ö´_µoªº¯f¤H¨Ó»¡¡A¶Ê¯v¯à°÷À°§U¥L­Ì¦³®Ä±±¨î¯f±¡ ¡C¤T¤Q¦ì±w¦³¤Q¤G«ü¸z¼ìºÅªº¯f¤H³Q¦w±Æ§@¬°¬ã¨s¹ï¶H¡C¥L­Ì³£¦³®e©ö´_µoªº¯f±¡¡C¥L­Ì³Q¤À¦¨¨â²Õ¡C²Ä¤@²Õ¥u±µ¨ü‰xª«ªvÀø¡A²Ä¤G²Õ¦b¤Q¬P´Á¤º³Q¦w±Æ±µ¨üÃĪ«¥H¤Î¶Ê¯vªvÀø¡Cµ²ªGÅã¥Ü¡A©Ò¦³¥u±µ¨üÃĪ«ªvÀøªº¯f¤H³£¦³´_µo¡A¥i¬O²Ä¤G²Õªº¯f¤H·í¤¤¥u¦³¤@¥bªº¯f¤H¥X²{´_µoªº±¡ªp¡C (Colgan 1988)

¶Ê¯v¥ç´¿¸g³Qµý¹ê¹ï©óµÎ½w®ð³Ý¯f (Asthma) ¥ç«D±`¦³®Ä ¡C­^°êÂå¾Ç´Á¥Z (British Medical Journal) ³Q»{¬°¬O­^°êÂå¾Ç¬ÉªºÅv«Â¥Zª«¡C´¿¸g¦³¤@¦¸¤½¶}¤F¤@­Ó¦³Ãö¶Ê¯vªº¬ã¨s¡C³o­Ó¬ã¨sÅã¥Ü¹ï©ó±µ¨ü¶Ê¯vªvÀøªº¯f±wªÌ¨Ó»¡ , ®ð³Ý¯f¥X²{ªºÀW²v¥H¤Î»Ý­nªA¥ÎÃĪ«ªº¾¯¶q¤ñ°_±µ¨ü¶Ç²ÎªvÀøªº¯f¤H¬Û¹ï¸û¤Ö¡C (Maher-Loughnan 1962)

¦b¥t¤@­Ó ¦³Ãö¶Ê¯v¤îµhªº¬ã¨s ¤¤ , ¤@²Õ±w¦³¨ÅÀù (Breast cancer) ªº¤k¤h±µ¨ü¤@¦~ªº¤p²Õ¶Ê¯vªvÀø¡A³o²Õ¤k¤h¤ñ°_¥t¥~¤@¨Ç¨S¦³±µ¨ü¶Ê¯vªvÀøªº¨ÅÀù¤k¯f¤H¨Ó»¡ , µo²{Àù¯g±aµ¹¦o­Ìªºµh·¡¤U­°¤F 50% ¡C (Spiegel 1983)

¶Ê¯v¥ç´¿¸g³Q¥Î§@¬ã¨sªvÀø¥¢¯vªº®ÄªG¡Aµ²ªG¥O¤H«D±`¹ª»R ¡C¥|¤Q¤­¦ì´ú¸Õ¹ï¶HÀH¾÷¦a¤À¬°¤T²Õ¡C²Ä¤@²Õ±µ¨ü¶Ê¯vªvÀø¡A²Ä¤G²Õ±µ¨ü¦w¼¢¾¯®ÄÀ³´ú¸Õ , ²Ä¤T²Õ¬O±±¨î²Õ , ¥L­Ì³sÄò±µ¨ü¥|¬P´Á¨C¬P´Á¤T¤Q¤ÀÄÁªºªvÀø¡C²Ä¤@²Õ¯f¤H¶i¤J¶Ê¯vª¬ºA¤§«á³Q¤Þ¾É·Q¹³¥h¤F¤@­Ó«ÜµÎªAªº¯S§Oªº¦a¤è , ¨Ã·t¥Ü¥[±j¥L­Ì¬O§Úªº¤O¶q¡A¨Ï¥L­Ì¯à°÷©ñ¶}¨º¨Ç§xÂZªº°ÝÃD¡C¦w¼¢¾¯®ÄÀ³ªº¤@²Õ¹ï¶H³Q¤Þ¾É·Q¹³¤@¨Ç¤¤¥ßªº¹Ï¹³¡Cµ²ªGÅã¥Ü¥u¦³±µ¨ü¶Ê¯vªvÀøªº¹ï¶H¯à°÷¦³®Ä§ïµ½¥L­ÌªººÎ¯vµ{«×¹F 50% ¡C ( Stanton 1989)

±q¥H¤WºØºØ¬ì¾Ç¬ã¨s¥i¥Hª¾¹D¡A¶Ê¯vªº¦Ó¥B½T¯à°÷±a¨Ó«Ü¦h¹ê½èªºÁ{§É®ÄªG¡A¦Ó¥B¨S¦³¥ô¦ó°Æ§@¥Î¡C¶Ê¯vªvÀø¤w¸g³Q¤½»{¬°¦¨¬°¤Ü¤@¥@¬ö¨ä¤¤¤@ºØ·¥¬°­«­nªºªvÀø¤èªk¡C

  ¦^³»³¡

Copyright©2008 by Raymond Lai. All right reserved. No part of this article can be reproduced in any form without the written permission of Raymond Lai.

Áp·ù¾÷ºc :

   

21/F, Go-up Commercial Building, 998 Canton Road, Mongkok, Kowloon, H.K.
©ô¨¤¼sªF¹D998¸¹°ª©ú°Ó·~¤j·H21¼Ó¥þ¼h
¹q¸Ü¡G23597012
¶Ç¯u¡G23597821
ºô§}¡Gwww.hk-chc.com